DrugInfoSys

Pentostatin

Also known as: deoxycoformycin, covidarabine, co-vidarabine, 2-deoxycoformycin

Drug #1878

Pentostatin is purine metabolite used as chemotherapeutic agent in cancer therapy particularly in hairy-cell leukemia.It is a potent inhibitor of adenosine deaminase and has immunosuppressive activity.it is isolated from fermentation cultures of streptomyces antibioticus.

Primary Characteristics

Pentostatin is also known as deoxycoformycin, covidarabine, co-vidarabine, 2-deoxycoformycin.

It is of Natural origin and belongs to purine analog.

It belongs to Antimetabolites (DNA acting) pharmacological group on the basis of mechanism of action and also classified in Antineoplastic Agent pharmacological group.

Molecular Weight: 268.27 · Non-proprietary name: Pentostatin.

Molecular structure of Pentostatin

Pharmacokinetics

Distribution: Pentostatin has a volume of distribution is 10-12.5%. plasma protein binding is 4%.

Elimination: it is metabolised via hepatic(minor), plasma half-life is 5-7 hours, renal excretion is 90%.

Advertisement

Indications

Pentostatin is primarily indicated in conditions like Hairy cell leukaemia.

Pentostatin is also indicated for secondary conditions like Non-hodgkin's lymphoma, Non-hodgkin's lymphoma.

Contraindications

Pentostatin is contraindicated in conditions like Pregnancy.

Dosage

Pentostatin's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
4 mg/m24 mg/m2IVAntiemetic should be given for 48-74 hours after pentostatin administration.
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

Major5 interactions
Minor3 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Pentostatin in overdosage may give rise to further complications which include Anemia , Anemia , Hepatotoxicity , Neutropenia , Immune suppression , Anemia.

Pentostatin produces potentially life-threatening effects which include Myelosuppression . Careful monitoring is needed with proper medical management.

The signs and symptoms that are produced after acute overdosage of Pentostatin are Renal insufficiency, Liver dysfunction, CNS effects.

Pentostatin is known to cause more or less tolerable side effects which are usually transient. These include Abdominal pain, Chills, Fever, GI disturbance, Headache.

Warnings / Precautions

If tiredness,anxiety,depression,sleep disturbance and paraesthesia occur medicine should be discontiued.Close monitoring of the patient should be done for bone marrow depression and other effects.

Interference in Pathology

Pentostatin may interfere in the diagnosis of SGPT level disturbance. , Aspartate Aminotransferase Assay .

Available Brands

None recorded.

Drug Classification

  1. 1.8.2Cytotoxic (anti-neoplastic) drugs